ArticleStroke (Hoboken, N.J.)2021

Vorapaxar as an Alternative for Ticagrelor Resistance in Neuroendovascular Intervention.

James C Mamaril-Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.